Summary
This position statement represents the recommendations of the Austrian Diabetes Association regarding the clinical diagnostic and therapeutic application, safety and benefits of continuous subcutaneous glucose monitoring systems in patients with diabetes mellitus, based on current evidence.
Zusammenfassung
Das Positionspapier repräsentiert die Empfehlungen der ÖDG zur diagnostischen und therapeutischen Anwendung der kontinuierlichen Glukosemessung bei Erwachsenen und Kindern mit Diabetes mellitus basierend auf der zurzeit zur Verfügung stehenden Evidenz.
Similar content being viewed by others
Literatur
Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA. STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311–320. 2010;363(11):1092.
Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O’Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group.N Engl J Med. 2008;359(14):1464–76.
Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, Jeandidier N, Nicolino M. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care. 2009;32(12):2245–50.
Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29(12):2730–32.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009;32(8):1378–83.
Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, Fowler D, Campbell PJ, Temple RC. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ. 2008;25:337:a1680. doi:10.1136/bmj.a1680.
Kordonouri O, Pankowska E, Rami B Kapellen T, Coutant R, Hartmann R, Lange K, Knip M, Danne T. Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study(ONSET) after 12 months of treatment. Diabetologia, 2010;53(12):2487–95.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schütz-Fuhrmann, I., Schober, E., Rami, B. et al. Positionspapier des Insulinpumpenausschusses der OEDG zur kontinuierlichen Glukosemessung (CGM – Continuous Glucose Monitoring). Wien Klin Wochenschr 124 (Suppl 2), 120–122 (2012). https://doi.org/10.1007/s00508-012-0291-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-012-0291-1